Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee

1.

Cisternas M, Murphy L, Sacks J, Solomon D, Pasta D, Helmick C. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res. 2016;68:574–80. https://doi.org/10.1002/acr.22721.CrossRef

2.

Sibille K, Chen H, Bartley E, Riley J, Glover T, King C, et al. Accelerated aging in adults with knee osteoarthritis pain. Pain Rep. 2017;2:e591. https://doi.org/10.1097/PR9.0000000000000591.CrossRefPubMedPubMedCentral

3.

Torio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204. 2016 May. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. Available from: https://www.ncbi.nlm.nih.gov/books /NBK368492/. Accessed 15 July 2018.

4.

Zhao L, Kaye AD, Abd-Elsayed A. Stem cells for the treatment of knee osteoarthritis: a comprehensive review. Pain Physician. 2018;21:229–41.PubMed

5.

Torstensen TA, Grooten WJA, Østerås H, Heijne A, Harms-Ringdahl K, Äng BO. How does exercise dose affect patients with long-term osteoarthritis of the knee? A study protocol of a randomised controlled trial in Sweden and Norway: the SWENOR Study. BMJ Open. 2018;8:e018471. https://doi.org/10.1136/bmjopen-2017-018471.CrossRefPubMedPubMedCentral

6.

Lai L, Stitik T, Foye P, Georgy J, Patibanda V, Chen B. Use of platelet-rich plasma in intra-articular knee injections for osteoarthritis: a systematic review. PM R. 2015;7:637–48. https://doi.org/10.1016/j.pmrj.2015.02.003.CrossRef

7.

Ayhan E. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5:351–61. https://doi.org/10.5312/wjo.v5.i3.351.CrossRefPubMedPubMedCentral

8.

Laver L, Marom N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A. PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage. 2016;8:341–64. https://doi.org/10.1177/1947603516670709.CrossRefPubMedPubMedCentral

9.

Jang S, Kim J, Cha S. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 2012;23:573–80. https://doi.org/10.1007/s00590-012-1037-5.CrossRefPubMed

10.

Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005;24:1–12. https://doi.org/10.1016/j.csm.2004.08.007.CrossRefPubMed

11.

Martel-Pelletier J, Boileau C, Pelletier J, Roughley P. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22:351–84. https://doi.org/10.1016/j.berh.2008.02.001.CrossRefPubMed

12.

Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, et al. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res. 2017;352:146–56. https://doi.org/10.1016/j.yexcr.2017.02.012.CrossRefPubMed

13.

Murray I, Benke M, Mandelbaum B. Management of knee articular cartilage injuries in athletes: chondroprotection, chondrofacilitation, and resurfacing. Knee Surg Sports Traumatol Arthrosc. 2015;24:1617–26. https://doi.org/10.1007/s00167-015-3509-8.CrossRefPubMed

14.

LaPrade R, Dragoo J, Koh J, Murray I, Geeslin A, Chu C. AAOS research symposium updates and consensus. J Am Acad Orthop Surg. 2016;24:e62–78. https://doi.org/10.5435/JAAOS-D-16-00086.CrossRefPubMedPubMedCentral

15.

Zlotnicki J, Geeslin A, Murray I, Petrigliano F, LaPrade R, Mann B, et al. Biologic treatments for sports injuries II think tank—current concepts, future research, and barriers to advancement, part 3. Orthop J Sports Med. 2016;4:232596711664243. https://doi.org/10.1177/2325967116642433.CrossRef

16.

Kanchanatawan W, Arirachakaran A, Chaijenkij K, Prasathaporn N, Boonard M, Piyapittayanun P, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2015;24:1665–77. https://doi.org/10.1007/s00167-015-3784-4.CrossRefPubMed

17.

Campbell K, Erickson B, Saltzman B, Mascarenhas R, Bach B, Cole B, et al. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy. 2015;31:2036–2045.e14. https://doi.org/10.1016/j.arthro.2015.03.030.CrossRefPubMed

18.

Patil S, McCauley J, Pulido P, Colwell C. How do knee implants perform past the second decade? Nineteen- to 25-year followup of the press-fit condylar design TKA. Clin Orthop Relat Res. 2014;473:135–40. https://doi.org/10.1007/s11999-014-3792-6.CrossRefPubMedCentral

19.

Beswick A, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2:e000435. https://doi.org/10.1136/bmjopen-2011-000435.CrossRefPubMedPubMedCentral

20.

Walker L, Clement N, Deehan D. Predicting the outcome of total knee arthroplasty using the womac score: a review of the literature. J Knee Surg. 2018. https://doi.org/10.1055/s-0038-1666866.

21.

Zhang W, Robertson J, Jones A, Dieppe P, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67:1716–23. https://doi.org/10.1136/ard.2008.092015.CrossRefPubMed

22.

Wang P, Yang L, Li H, Lei Z, Yang X, Liu C, et al. Effects of whole-body vibration training with quadriceps strengthening exercise on functioning and gait parameters in patients with medial compartment knee osteoarthritis: a randomised controlled preliminary study. Physiotherapy. 2016;102:86–92. https://doi.org/10.1016/j.physio.2015.03.3720.CrossRefPubMed

23.

Levy D, Petersen K, Scalley Vaught M, Christian D, Cole B. Injections for knee osteoarthritis: corticosteroids, Viscosupplementation, platelet-rich plasma, and autologous stem cells. Arthroscopy. 2018;34:1730–43. https://doi.org/10.1016/j.arthro.2018.02.022.CrossRefPubMed

24.

Bennell K, Hunter D, Paterson K. Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep. 2017;19:24. https://doi.org/10.1007/s11926-017-0652-x.CrossRefPubMed

25.

Foster T, Puskas B, Mandelbaum B, Gerhardt M, Rodeo S. Platelet-rich plasma. Am J Sports Med. 2009;37:2259–72. https://doi.org/10.1177/0363546509349921.CrossRefPubMed

26.

Whitney K, Liebowitz A, Bolia I, Chahla J, Ravuri S, Evans T, et al. Current perspectives on biological approaches for osteoarthritis. Ann N Y Acad Sci. 2017;1410:26–43. https://doi.org/10.1111/nyas.13554.CrossRefPubMed

27.

Sundman E, Cole B, Karas V, Della Valle C, Tetreault M, Mohammed H, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2013;42:35–41. https://doi.org/10.1177/0363546513507766.CrossRefPubMed

28.

Chahla J, Mandelbaum B. Biological treatment for osteoarthritis of the knee: moving from bench to bedside—current practical concepts. Arthroscopy. 2018;34:1719–29. https://doi.org/10.1016/j.arthro.2018.01.048.CrossRefPubMed

29.

Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014;7:189–97. https://doi.org/10.4103/0974-2077.150734.CrossRefPubMedPubMedCentral

30.

Machlus K, Thon J, Italiano J. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol. 2014;165:227–36. https://doi.org/10.1111/bjh.12758.CrossRefPubMed

31.

Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91:411–7. https://doi.org/10.1097/PHM.0b013e3182aab72.CrossRefPubMed

32.

Sánchez-González D, Méndez-Bolaina E, Trejo-Bahena N. Platelet-rich plasma peptides: key for regeneration. Int J Pept. 2012;2012:1–10. https://doi.org/10.1155/2012/532519.CrossRef

33.

Ludwig H, Birdwhistell K, Brainard B, Franklin S. Use of a cyclooxygenase-2 inhibitor does not inhibit platelet activation or growth factor release from platelet-rich plasma. Am J Sports Med. 2017;45:3351–7. https://doi.org/10.1177/0363546517730578.CrossRefPubMed

34.

Cole B, Seroyer S, Filardo G, Bajaj S, Fortier L. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010;2:203–10. https://doi.org/10.1177/1941738110366385.CrossRefPubMedPubMedCentral

35.

Watson S, Bahou W, Fitzgerald D, Ouwehand W, Rao A, Leavitt A. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost. 2005;3:2098–101. https://doi.org/10.1111/j.1538-7836.2005.01550.x.CrossRefPubMed

36.

Xie X, Zhang C, Tuan R. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16:204. https://doi.org/10.1186/ar4493.CrossRef

37.

Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013;29:2037–48. https://doi.org/10.1016/j.arthro.2013.09.006.CrossRef

38.

Zhu Y, Yuan M, Meng H, Wang A, Guo Q, Wang Y, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthr Cartil. 2013;21:1627–37. https://doi.org/10.1016/j.joca.2013.07.017.CrossRef

39.

Nöth U, Rackwitz L, Heymer A, Weber M, Baumann B, Steinert A, et al. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. J Biomed Mater Res A. 2007;83A:626–35. https://doi.org/10.1002/jbm.a.31254.CrossRef

40.

Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2010;19:516–27. https://doi.org/10.1007/s00167-010-1306-y.CrossRefPubMed

41.

Nasi S, Ea H, So A, Busso N. Revisiting the role of interleukin-1 pathway in osteoarthritis: interleukin-1α and -1β, and NLRP3 inflammasome are not involved in the pathological features of the murine menisectomy model of osteoarthritis. Front Pharmacol 2017;8. https://doi.org/10.3389/fphar.2017.00282.

42.

Braun H, Wasterlain A, Dragoo J. The use of PRP in ligament and meniscal healing. Sports Med Arthrosc Rev. 2013;21:206–12. https://doi.org/10.1097/JSA.0000000000000005.CrossRefPubMed

43.

Schmidt M, Chen E, Lynch S. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthr Cartil. 2006;14:403–12. https://doi.org/10.1016/j.joca.2005.10.011.CrossRef

44.

Yin W, Xu H, Sheng J, An Z, Guo S, Xie X, et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in treating rabbit knee osteoarthritis. Med Sci Monit. 2016;22:1280–90. https://doi.org/10.12659/MSM.898218.CrossRefPubMedPubMedCentral

45.

Deasy B, Feduska J, Payne T, Li Y, Ambrosio F, Huard J. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther. 2009;17:1788–98. https://doi.org/10.1038/mt.2009.136.CrossRefPubMedPubMedCentral

46.

Filardo G, Kon E, Pereira Ruiz M, Vaccaro F, Guitaldi R, Di Martino A, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2011;20:2082–91. https://doi.org/10.1007/s00167-011-1837-x.CrossRefPubMed

47.

Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17:602–8.CrossRefPubMed

48.

Sundman E, Cole B, Fortier L. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39:2135–40. https://doi.org/10.1177/0363546511417792.CrossRefPubMed

49.

McCarrel T, Minas T, Fortier L. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg. 2012;94:e143. https://doi.org/10.2106/JBJS.L.00019.CrossRefPubMed

50.

Anitua E, Troya M, Zalduendo M, Orive G. The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors. Ann Anat. 2014;196:423–9. https://doi.org/10.1016/j.aanat.2014.06.002.CrossRefPubMed

51.

Boswell S, Cole B, Sundman E, Karas V, Fortier L. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–39. https://doi.org/10.1016/j.arthro.2011.10.018.CrossRefPubMed

52.

Braun H, Kim H, Chu C, Dragoo J. The effect of platelet-rich plasma formulations and blood products on human synoviocytes. Am J Sports Med. 2014;42:1204–10. https://doi.org/10.1177/0363546514525593.CrossRefPubMedPubMedCentral

53.

• Meheux C, McCulloch P, Lintner D, Varner K, Harris J. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy. 2016;32:495–505. https://doi.org/10.1016/j.arthro.2015.08.005 A recent systematic review focusing on level I evidence available for PRP treatment in KOA and indicating significant clinical improvements for up to 12 months post-injection. CrossRefPubMed

54.

Bendinelli P, Matteucci E, Dogliotti G, Corsi M, Banfi G, Maroni P, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol. 2010;225:757–66. https://doi.org/10.1002/jcp.22274.CrossRefPubMed

55.

Scanzello C, Goldring S. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249–57. https://doi.org/10.1016/j.bone.2012.02.012.CrossRefPubMedPubMedCentral

56.

Cavallo C, Filardo G, Mariani E, Kon E, Marcacci M, Pereira Ruiz M, et al. Comparison of platelet-rich plasma formulations for cartilage healing. J Bone Joint Surg Am. 2014;96:423–9. https://doi.org/10.2106/JBJS.M.00726.CrossRefPubMed

57.

Xu Z, Luo J, Huang X, Wang B, Zhang J, Zhou A. Efficacy of platelet-rich plasma in pain and self-report function in knee osteoarthritis. Am J Phys Med Rehabil. 2017;96:793–800. https://doi.org/10.1097/PHM.0000000000000746.CrossRefPubMed

58.

Muraglia A, Ottonello C, Spanò R, Dozin B, Strada P, Grandizio M, et al. Biological activity of a standardized freeze-dried platelet derivative to be used as cell culture medium supplement. Platelets. 2013;25:211–20. https://doi.org/10.3109/09537104.2013.803529.CrossRefPubMed

59.

Chien C, Ho H, Liang Y, Ko P, Sheu M, Chen C. Incorporation of exudates of human platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilage. J Biomed Mater Res B Appl Biomater. 2012;100B:948–55. https://doi.org/10.1002/jbm.b.32657.CrossRef

60.

Wu C, Chen W, Zao B, Lai P, Lin T, Lo H, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials. 2011;32:5847–54. https://doi.org/10.1016/j.biomaterials.2011.05.002.CrossRefPubMed

61.

Spreafico A, Chellini F, Frediani B, Bernardini G, Niccolini S, Serchi T, et al. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem. 2009;108:1153–65. https://doi.org/10.1002/jcb.22344.CrossRefPubMed

62.

Akeda K, An H, Okuma M, Attawia M, Miyamoto K, Thonar E, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartil. 2006;14:1272–80. https://doi.org/10.1016/j.joca.2006.05.008.CrossRef

63.

Holmes H, Wilson B, Goerger J, Silverberg J, Cohen I, Zipfel W, et al. Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma. PLoS One. 2018;13:e0194567. https://doi.org/10.1371/journal.pone.0194567.CrossRefPubMedPubMedCentral

64.

Smyth N, Murawski C, Fortier L, Cole B, Kennedy J. Platelet-rich plasma in the pathologic processes of cartilage: review of basic science evidence. Arthroscopy. 2013;29:1399–409. https://doi.org/10.1016/j.arthro.2013.03.004.CrossRefPubMed

65.

Sakata R, McNary S, Miyatake K, Lee C, Van den Bogaerde J, Marder R, et al. Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma. Am J Sports Med. 2015;43:1467–73. https://doi.org/10.1177/0363546515575023.CrossRefPubMedPubMedCentral

66.

Quicke J, Foster N, Thomas M, Holden M. Is long-term physical activity safe for older adults with knee pain?: a systematic review. Osteoarthr Cartil. 2015;23:1445–56. https://doi.org/10.1016/j.joca.2015.05.002.CrossRef

67.

Juhl C, Christensen R, Roos E, Zhang W, Lund H. Impact of exercise type and dose on pain and disability in knee osteoarthritis: a systematic review and meta-regression analysis of randomized controlled trials. Arthritis Rheum. 2014;66:622–36. https://doi.org/10.1002/art.38290.CrossRef

68.

Bricca A, Juhl C, Steultjens M, Wirth W, Roos E. Impact of exercise on articular cartilage in people at risk of, or with established, knee osteoarthritis: a systematic review of randomised controlled trials. Br J Sports Med. 2018. https://doi.org/10.1136/bjsports-2017-098661.

69.

Felson DT, Zhang Y, Anthony JM, Naimark Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in woman. The Framingham Study. Ann Intern Med. 1992;116:535–9.CrossRefPubMed

70.

Laudy A, Bakker E, Rekers M, Moen M. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2014;49:657–72. https://doi.org/10.1136/bjsports-2014-094036.CrossRefPubMed

71.

Lazaridou A, Martel M, Cornelius M, Franceschelli O, Campbell C, Smith M, et al. The association between daily physical activity and pain among patients with knee osteoarthritis: the moderating role of pain catastrophizing. Pain Medicine. 2018. https://doi.org/10.1093/pm/pny129.

72.

Baxter S, Hale L, Stebbings S, Gray A, Smith C, Treharne G. Walking is a feasible physical activity for people with rheumatoid arthritis: a feasibility randomized controlled trial. Musculoskeletal Care. 2015;14:47–56. https://doi.org/10.1002/msc.1112.CrossRefPubMed

73.

Harden R, Wallach G, Gagnon C, Zereshki A, Mukai A, Saracoglu M, et al. The osteoarthritis knee model: psychophysical characteristics and putative outcomes. J Pain. 2013;14:281–9. https://doi.org/10.1016/j.jpain.2012.11.009.CrossRefPubMed

74.

Rosemann T, Laux G, Szecsenyi J, Wensing M, Grol R. Pain and osteoarthritis in primary care: factors associated with pain perception in a sample of 1,021 patients. Pain Med. 2008;9:903–10. https://doi.org/10.1111/j.1526-4637.2008.00498.x.CrossRefPubMed

75.

Saccomanno M, Donati F, Careri S, Bartoli M, Severini G, Milano G. Efficacy of intra-articular hyaluronic acid injections and exercise-based rehabilitation programme, administered as isolated or integrated therapeutic regimens for the treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015;24:1686–94. https://doi.org/10.1007/s00167-015-3917-9.CrossRefPubMed

76.

Campbell K, Saltzman B, Mascarenhas R, Khair M, Verma N, Bach B, et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015;31:2213–21. https://doi.org/10.1016/j.arthro.2015.03.041.CrossRefPubMed

77.

Clegg D, Reda D, Harris C, Klein M, O'Dell J, Hooper M, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808. https://doi.org/10.1056/NEJMoa052771.CrossRefPubMed

78.

Michael J, Schlüter-Brust K, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010;107(9):152–62. https://doi.org/10.3238/arztebl.2010.0152.CrossRefPubMedPubMedCentral

79.

Bert J, Bert T. Nonoperative treatment of unicompartmental arthritis. Clin Sports Med. 2014;33:1–10. https://doi.org/10.1016/j.csm.2013.08.002.CrossRefPubMed

80.

Simental-Mendía M, Vílchez-Cavazos J, Peña-Martínez V, Said-Fernández S, Lara-Arias J, Martínez-Rodríguez H. Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016;136:1723–32. https://doi.org/10.1007/s00402-016-2545-2.CrossRefPubMed

81.

Osterman C, McCarthy M, Cote M, Beitzel K, Bradley J, Polkowski G, et al. Platelet-rich plasma increases anti-inflammatory markers in a human coculture model for osteoarthritis. Am J Sports Med. 2015;43:1474–84. https://doi.org/10.1177/0363546515570463.CrossRefPubMed

82.

Richards M, Maxwell J, Weng L, Angelos M, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed. 2016;44:101–8. https://doi.org/10.1080/00913847.2016.1168272.CrossRefPubMedPubMedCentral

83.

Jüni P, Hari R, Rutjes A, Fischer R, Silletta M, Reichenbach S et al. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015. Issue 10. Art. No.: CD005328. https://doi.org/10.1002/14651858.CD005328.pub3.

84.

MacMahon P, Eustace S, Kavanagh E. Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology. 2009;252:647–61. https://doi.org/10.1148/radiol.2523081929.CrossRefPubMed

85.

Raynauld J, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48:370–7. https://doi.org/10.1002/art.10777.CrossRefPubMed

86.

McAlindon T, LaValley M, Harvey W, Price L, Driban J, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis. JAMA. 2017;317:1967–75. https://doi.org/10.1001/jama.2017.5283.CrossRefPubMedPubMedCentral

87.

Joshi Jubert N, Rodríguez L, Reverté-Vinaixa M, Navarro A. Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial. Orthop J Sports Med. 2017;5(2):232596711668938. https://doi.org/10.1177/2325967116689386.CrossRef

88.

Forogh B, Mianehsaz E, Shoaee S, Ahadi T, Raissi GR, Sajadi S. Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness. 2016;56(7–8):901–8.PubMed

89.

Saltzman B, Leroux T, Meyer M, Basques B, Chahal J, Bach B, et al. The therapeutic effect of intra-articular normal saline injections for knee osteoarthritis: a meta-analysis of evidence level 1 studies. Am J Sports Med. 2016;45:2647–53. https://doi.org/10.1177/0363546516680607.CrossRefPubMed

90.

Vannabouathong C, Bhandari M, Bedi A, Khanna V, Yung P, Shetty V, et al. Nonoperative treatments for knee osteoarthritis. JBJS Reviews. 2018;6(7):e5. https://doi.org/10.2106/JBJS.RVW.17.00167.CrossRefPubMed

91.

Görmeli G, Görmeli C, Ataoglu B, Çolak C, Aslantürk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2015;25:958–65. https://doi.org/10.1007/s00167-015-3705-6.CrossRefPubMed

92.

Patel S, Dhillon M, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis. Am J Sports Med. 2013;41:356–64. https://doi.org/10.1177/0363546512471299.CrossRefPubMed

93.

• Smith P. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis. Am J Sports Med. 2016;44:884–91. https://doi.org/10.1177/0363546515624678 FDA-regulated, double-blind, placebo-controlled study demonstrating significantly greater improvements in patients treated with LP-PRP compared to saline up to 12 months. CrossRefPubMed

94.

Duymus T, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas F. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surg Sports Traumatol Arthrosc. 2016;25:485–92. https://doi.org/10.1007/s00167-016-4110-5.CrossRefPubMed

95.

• Cole B, Karas V, Hussey K, Merkow D, Pilz K, Fortier L. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2016;45:339–46. https://doi.org/10.1177/0363546516665809 Demonstrated increased efficacy of LP-PRP compared to HA in regards to patient-reported outcomes, and demonstrated a trend toward decreased inflammatory cytokines in LP-PRP compared to HA at 12 weeks. CrossRefPubMed

96.

Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3–9.PubMed

97.

Cerza F, Carnì S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40:2822–7. https://doi.org/10.1177/0363546512461902.CrossRefPubMed

98.

Vaquerizo V, Plasencia M, Arribas I, Seijas R, Padilla S, Orive G, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013;29:1635–43. https://doi.org/10.1016/j.arthro.2013.07.264.CrossRef

99.

Ahmad H, Farrag S, Okasha A, Kadry A, Ata T, Monir A, et al. Clinical outcomes are associated with changes in ultrasonographic structural appearance after platelet-rich plasma treatment for knee osteoarthritis. Int J Rheum Dis. 2018;21:960–6. https://doi.org/10.1111/1756-185X.13315.CrossRefPubMed

100.

Louis M, Magalon J, Jouve E, Bornet C, Mattei J, Chagnaud C, et al. Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation. Arthroscopy. 2018;34:1530–1540.e2. https://doi.org/10.1016/j.arthro.2017.11.035.CrossRefPubMed

101.

Montañez-Heredia E, Irízar S, Huertas P, Otero E, del Valle M, Prat I, et al. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the Spanish National Health Care System. Int J Mol Sci. 2016;17:1064. https://doi.org/10.3390/ijms17071064.CrossRefPubMedCentral

102.

Raeissadat S, Rayegani S, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, et al. Knee osteoarthritis injection choices: platelet- rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2015;8:1–8. https://doi.org/10.4137/CMAMD.S17894.CrossRefPubMedPubMedCentral

103.

Filardo G, Di Matteo B, Di Martino A, Merli M, Cenacchi A, Fornasari P, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation. Am J Sports Med. 2015;43:1575–82. https://doi.org/10.1177/0363546515582027.CrossRefPubMed

104.

Sánchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28:1070–8. https://doi.org/10.1016/j.arthro.2012.05.011.CrossRef

105.

Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis. Am J Phys Med Rehabil. 2010;89:961–9. https://doi.org/10.1097/PHM.0b013e3181fc7edf.CrossRefPubMed

106.

Filardo G, Kon E, DI Matteo B, DI Marino A, Sessa A, Merli ML, et al. Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 2014;1(3):112–20 eCollection 2013 Jul-Sep.

107.

Hurley E, Yasui Y, Gianakos A, Seow D, Shimozono Y, Kerkhoffs G, et al. Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2018. https://doi.org/10.1007/s00167-018-4955-x.CrossRefPubMed

108.

Chahla J, Piuzzi N, Mitchell J, Dean C, Pascual-Garrido C, LaPrade R, et al. Intra-articular cellular therapy for osteoarthritis and focal cartilage defects of the knee. J Bone Joint Surg. 2016;98:1511–21. https://doi.org/10.2106/JBJS.15.01495.CrossRefPubMed

109.

Pas H, Winters M, Haisma H, Koenis M, Tol J, Moen M. Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med. 2017;51:1125–33. https://doi.org/10.1136/bjsports-2016-096793.CrossRefPubMed

110.

Koh Y, Choi Y. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19:902–7. https://doi.org/10.1016/j.knee.2012.04.001.CrossRefPubMed

111.

Kim J, Lee G, Jung G, Kim C, Kim T, Park J, et al. Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. European Journal of Orthopaedic Surgery & Traumatology. 2014;24:1505–11. https://doi.org/10.1007/s00590-013-1393-9.CrossRef

112.

Centeno C, Pitts J, Al-Sayegh H, Freeman M. Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int. 2014;2014:1–9. https://doi.org/10.1155/2014/370621.CrossRef

113.

Shaw B, Darrow M, Derian A. Short-term outcomes in treatment of knee osteoarthritis with 4 bone marrow concentrate injections. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2018;11:117954411878108. https://doi.org/10.1177/1179544118781080.CrossRef

114.

• Shapiro S, Kazmerchak S, Heckman M, Zubair A, O’Connor M. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2016;45:82–90. https://doi.org/10.1177/0363546516662455 Placebo-controlled trial finding no significant improvement between patients treated with saline and BMAC in KOA. CrossRefPubMed

115.

Piuzzi NS, Ng M, Chughtai M, Khlopas A, Ng K, Mont MA, et al. The stem-cell market for the treatment of knee osteoarthritis: a patient perspective. J Knee Surg. 2018;31(6):551–6. https://doi.org/10.1055/s-0037-1604443.CrossRefPubMed

116.

• Chahla J, Cinque M, Piuzzi N, Mannava S, Geeslin A, Murray I, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting. J Bone Joint Surg Am. 2017;99:1769–79. https://doi.org/10.2106/JBJS.16.01374 An important statement to researchers involving the importance of standardization in PRP protocols, methods, and reporting. CrossRefPubMed

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee

Abstract

Purpose of Review

Recent Findings

Summary

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2018

Evolution in Management of Tibial Pilon Fractures

Platelet-Rich Plasma: Review of Current Literature on its Use for Tendon and Ligament Pathology

Evaluation and Management of Pyogenic and Tubercular Spine Infections

Treatment of Muscle Injuries with Platelet-Rich Plasma: a Review of the Literature

Current Clinical Recommendations for Use of Platelet-Rich Plasma

Platelet-Rich Plasma for Elbow Pathologies: a Descriptive Review of Current Literature